VAS 3947, a specific NADPH oxidase (NOX) inhibitor, exerts a potent antiplatelet effect. VAS3947 induces apoptosis independently of anti-NOX activity, via UPR activation, mainly due to aggregation and misfolding of proteins.
In Vitro
VAS3947 consistently inhibits NADPH oxidase activity in low micromolar concentrations, and interferes neither with ROS detection nor with XOD or eNOS activities. VAS3947 (30 µM) does not interfere with xanthine/XOD-derived L012 signals, suggesting this compound is free of antioxidant or scavenging effects relevant to ROS detection. In CaCo-2 cell homogenates, VAS3947 completely blocks NADPH-dependent ROS production with an IC 50 of 12 µM. VAS3947 triggers cell proliferation arrest and death independently of anti-NOX activity. The IC 50 values of the different cell lines ranges from 2.6 ± 0.6 µM for the most sensitive cell line MV-4-11 to 4.9 µM for THP-1, the least sensitive. VAS3947 decreases ROS levels. VAS3947 triggers endoplasmic reticulum (ER) stress and consequent unfolding protein response (UPR). VAS3947 attenuates platelet activation and thrombus formation via a NOX-independent pathway downstream of PKC 3] . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
NADPH 氧化酶抑制剂 MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
规格
别名
2-((3-苄基-3H-[1,2,3]三唑并[4,5-d]嘧啶-7-基)硫基)恶唑
英文别名
2-((3-benzyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)thio)oxazole | VA-S3947 | VAS3947 | VA S3947
规格或纯度
Moligand™,≥99%
英文名称
VAS 3947
生化机理
VAS 3947 是一种特异性 NADPH 氧化酶(NOX)抑制剂,具有强效抗血小板作用。VAS3947 可通过 UPR 激活(主要是由于蛋白质的聚集和错误折叠)诱导细胞凋亡,而与抗 NOX 活性无关。